These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7636501)

  • 1. Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone/interferon alpha 2b treatment of chronic hepatitis B virus infection.
    Fei GZ; Sylvan SP; Hellström UB; Yao GB
    J Med Virol; 1995 Jun; 46(2):138-43. PubMed ID: 7636501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgM anti-preS2 monitoring during combined corticosteroid/interferon-alpha 2b therapy in chronic hepatitis B.
    Fei GZ; Sylvan SP; Hellström UB; Yao GB
    Liver; 1991 Dec; 11(6):358-64. PubMed ID: 1779715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semiquantitative anti-HBc IgM detection in children with chronic hepatitis B: a long-term follow-up study.
    Gaeta GB; Nardiello S; Pizzella T; Russo G; Maisto A; Sardaro C; Galanti B; Giusti G
    J Med Virol; 1995 Jul; 46(3):173-7. PubMed ID: 7561786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
    Marinos G; Smith HM; Naoumov NV; Williams R
    Hepatology; 1994 Feb; 19(2):303-11. PubMed ID: 8294088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of IgM, IgA, and IgG antibodies to preS2 antigen in hepatitis B virus infection.
    Suga M; Arima K; Yachi A
    Digestion; 1991; 50(3-4):153-61. PubMed ID: 1812042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B.
    Hellström U; Lindh M; Krogsgaard K; Sylvan S
    J Gastroenterol Hepatol; 2008 May; 23(5):804-10. PubMed ID: 17931371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in anti-idiotype antibodies against anti-HBs during recombinant interferon treatment of chronic hepatitis B.
    Ibarra MZ; Porres JC; Bartolome FJ; Escudero M; Quiroga JA; Carreño V
    J Interferon Res; 1990 Aug; 10(4):367-73. PubMed ID: 2230344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of serum hepatitis B e antigen, IgM hepatitis B core antibody and HBV DNA in monitoring the response to treatment in patients with chronic hepatitis B.
    Bernard F; Raymond G; Willems B; Villeneuve JP
    J Viral Hepat; 1997 Jul; 4(4):265-72. PubMed ID: 9278224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the correlation between PreS1-Ag, PreS2-Ag, HBeAg and HBV DNA in the serum of chronic hepatitis B patients].
    Dou YL; Han JH; Li YZ; DI Q; Ni AP
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1984-6. PubMed ID: 17923040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged and high dose recombinant interferon alpha-2b alone or after prednisone priming accelerates termination of active viral replication in children with chronic hepatitis B infection.
    Vajro P; Tedesco M; Fontanella A; De Vincenzo A; Vecchione R; Ammendola R; Terracciano LM; Novissimo A; Vegnente A
    Pediatr Infect Dis J; 1996 Mar; 15(3):223-31. PubMed ID: 8852910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope.
    Park JH; Lee MK; Kim HS; Kim KL; Cho EW
    J Viral Hepat; 2003 Jan; 10(1):70-9. PubMed ID: 12558915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H; Sominskaya I; Pumpens P; Pushko P; Borisova G; Deepen R; Lu X; Spiller GH; Krüger DH; Grens E
    Intervirology; 1994; 37(6):330-9. PubMed ID: 8586531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.
    Sobotta D; Sominskaya I; Jansons J; Meisel H; Schmitt S; Heermann KH; Kaluza G; Pumpens P; Gerlich WH
    J Gen Virol; 2000 Feb; 81(Pt 2):369-78. PubMed ID: 10644835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PreS1 antigen/antibody patterns following interferon therapy in acute and chronic hepatitis B.
    Petit MA; Zoulim F; Berthillon P; Capel F; Li J; Dauguet C; Ferrari C; Trépo C
    J Hepatol; 1994 Jan; 20(1):47-56. PubMed ID: 8201222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of preS antigens and clinical status during chronic hepatitis B virus infection.
    Taliani G; Rapicetta M; Francisci D; Xiang J; Sarrecchia B; De Bac C; Stagni G
    Med Microbiol Immunol; 1991; 180(5):239-48. PubMed ID: 1762604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
    Günther S; Paulij W; Meisel H; Will H
    Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: cellular immune reactions and response to interferon treatment.
    Löhr H; Goergen B; Weber W; Gödderz W; Meyer zum Büschenfelde KH; Gerken G
    J Med Virol; 1994 Dec; 44(4):330-5. PubMed ID: 7897364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of interferon-alpha in five HIV-positive patients with chronic hepatitis B.
    di Martino V; Lunel F; Cadranel JF; Hoang C; Parlier Y; Le Charpentier Y; Opolon P
    J Viral Hepat; 1996 Sep; 3(5):253-60. PubMed ID: 8914005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.